Pippa Mann to Ring Nasdaq Stock Market Closing Bell on May 6th, 2016 Melbourne, Australia, 4 May 2016: Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a molecular diagnostics company specializing in women’s health, and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for sporadic breast cancer, announced today that it will visit the Nasdaq […]

Read the rest of this entry »